St. Louis, Oct. 01, 2026 (GLOBE NEWSWIRE) — ESCO Technologies Inc. (NYSE: ESE) today announced that it has completed the acquisition of the Megger Group Limited (Megger) business of TBG AG (TBG). Under the terms of the transaction, TBG has agreed to certain lock-up provisions with respect to its equity ownership in ESCO common stock and has nomination rights for one seat on ESCO’s Board of Directors. 

The acquisition of Megger supports ESCO’s long-term objective of expanding our leadership positions in high-growth end-markets. Megger is a leading global provider of testing, monitoring, and data-driven solutions for utilities and critical electric infrastructure and will become a part of our Utility Solutions Group segment. Megger adds a well-respected and differentiated product portfolio, with highly complementary capabilities, deep technical expertise, and strong customer and supplier relationships.   The addition of Megger expands the scale and international reach of ESCO’s utility product offerings, further strengthening our position as a valued partner to utilities worldwide.

The Company’s FY 2027 financial guidance and outlook, inclusive of impacts from the Megger acquisition, will be announced in November when Q4 2026 earnings are released.

ESCO is a global provider of highly engineered products and solutions serving diverse end-markets. It manufactures filtration and fluid control products, advanced composites, as well as signature and power management solutions for aviation, Navy, space, and industrial customers. ESCO is an industry leader in designing and manufacturing RF test and measurement products and systems; and provides diagnostic instruments, software and services to industrial power users and the electric utility and renewable energy industries. Headquartered in St. Louis, Missouri, ESCO and its subsidiaries have offices and manufacturing facilities worldwide. For more information on ESCO and its subsidiaries, visit ESCO’s website at www.escotechnologies.com.

SOURCE ESCO Technologies Inc.
Kate Lowrey, Vice President of Investor Relations, (314) 213-7277

CHICAGO, Oct. 01, 2026 (GLOBE NEWSWIRE) — XAI Madison Equity Premium Income Fund (the “Fund”) has declared its regular monthly distribution of $0.060 per share on the Fund’s common shares (NYSE: MCN), payable on November 2, 2026, to common shareholders of record as of October 15, 2026, as noted below. The amount of the distribution represents no change from the previous month’s distribution amount of $0.060 per share.

The following dates apply to the declaration:

Ex-Dividend Date October 15, 2026
   
Record Date October 15, 2026
   
Payable Date November 2, 2026
   
Amount $0.060 per share
   
Change from Previous Month No Change

Common share distributions may be paid from net investment income (regular interest and dividends), capital gains and/or a return of capital. The specific tax characteristics of the distributions will be reported to the Fund’s common shareholders on Form 1099 after the end of the 2026 calendar year. Shareholders should not assume that the source of a distribution from the Fund is net income or profit. For further information regarding the Fund’s distributions, please visit www.xainvestments.com.

The Fund’s net investment income and capital gain can vary significantly over time; however, the Fund seeks to maintain more stable common share quarterly distributions over time. The Fund’s final taxable income for the current fiscal year will not be known until the Fund’s tax returns are filed.

As a registered investment company, the Fund is subject to a 4% excise tax that is imposed if the Fund does not distribute to common shareholders by the end of any calendar year at least the sum of (i) 98% of its ordinary income (not taking into account any capital gain or loss) for the calendar year and (ii) 98.2% of its capital gain in excess of its capital loss (adjusted for certain ordinary losses) for a one-year period generally ending on December 31 of the calendar year (unless an election is made to use the Fund’s fiscal year). In certain circumstances, the Fund may elect to retain income or capital gain to the extent that the Board of Trustees, in consultation with Fund management, determines it to be in the interest of shareholders to do so.

The common share distributions paid by the Fund for any particular period may be more than the amount of net investment income from that period. As a result, all or a portion of a distribution may be a return of capital, which is in effect a partial return of the amount a common shareholder invested in the Fund, up to the amount of the common shareholder’s tax basis in their common shares, which would reduce such tax basis. Although a return of capital may not be taxable, it will generally increase the common shareholder’s potential gain, or reduce the common shareholder’s potential loss, on any subsequent sale or other disposition of common shares.

Future common share distributions will be made if and when declared by the Fund’s Board of Trustees, after the evaluation of several factors, including the Fund’s net investment income, financial performance and available cash. There can be no assurance that the amount or timing of common share distributions in the future will be equal or similar to that described herein or that the Board of Trustees will not decide to suspend or discontinue the payment of common share distributions in the future.

The Fund’s objective is to achieve a high level of current income and current capital gains, with long-term capital appreciation as a secondary objective. The Fund intends to pursue its objective by investing in a portfolio of common stocks and utilizing an option strategy, primarily by writing (selling) covered call options on a substantial portion of the common stocks in the portfolio in order to generate current income and gains from option writing premiums and, to a lesser extent, from dividends. Market action can impact dividend issuance as the Fund’s total assets affect the Fund’s future dividend prospects. The Fund provides additional information on its website at www.xainvestments.com.

About XA Investments

XA Investments LLC (“XAI”) serves as the Fund’s investment adviser. XAI is a Chicago-based firm founded by XMS Capital Partners in 2016. XAI serves as the investment adviser for two listed closed-end funds and an interval closed-end fund. The listed closed-end funds, the XAI Floating Rate & Alternative Income Trust and XAI Madison Equity Premium Income Fund both trade on the New York Stock Exchange and the interval fund, XAI CLO & Income Opportunities Fund is available via direct subscription and through select broker/dealers and wealth management platforms.

In addition to investment advisory services, the firm also provides investment fund structuring and consulting services focused on registered closed-end funds to meet institutional client needs. XAI offers custom product build and consulting services, including development and market research, sales, marketing, and fund management.

XAI believes that the investing public can benefit from new vehicles to access a broad range of alternative investment strategies and managers. XAI provides individual investors with access to institutional-caliber alternative managers. For more information, please visit www.xainvestments.com.

About XMS Capital Partners

XMS Capital Partners, LLC, established in 2006, is a global, independent, financial services firm providing M&A, corporate advisory and asset management services to clients. It has offices in Chicago, Boston and London. For more information, please visit www.xmscapital.com.

About Madison Investments

Madison Investments is an independent investment management firm based in Madison, WI. The firm was founded in 1974, has approximately $29.3 billion in assets under management as of June 30, 2026, and is recognized as one of the nation’s top investment firms. Madison offers domestic fixed income, U.S. and international equity, covered call, multi-asset, insurance and credit union investment management strategies. For more information, please visit www.madisoninvestments.com.

Madison and/or Madison Investments is the unifying tradename of Madison Investment Holdings, Inc., Madison Asset Management, LLC, and Madison Investment Advisors, LLC. Madison Funds are distributed by MFD Distributor, LLC. Madison is registered as an investment adviser with the U.S. Securities and Exchange Commission. MFD Distributor, LLC is registered with the U.S. Securities and Exchange Commission as a broker-dealer and is a member firm of the Financial Industry Regulatory Authority www.finra.org.

XAI does not provide tax advice; please consult a professional tax advisor regarding your specific tax situation. Income may be subject to state and local taxes, as well as the federal alternative minimum tax.

Investors should consider the investment objectives and policies, risk considerations, charges and expenses of the Fund carefully before investing. For more information on the Fund, please visit the Fund’s webpage at www.xainvestments.com.

This press release shall not constitute an offer to sell or a solicitation to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer or solicitation or sale would be unlawful prior to registration or qualification under the laws of such state or jurisdiction.

NOT FDIC INSURED NO BANK GUARANTEE MAY LOSE VALUE


Media Contact: 

Kimberly Flynn, President
XA Investments LLC
Phone: 888-903-3358
Email: KFlynn@XAInvestments.com
www.xainvestments.com

HOUSTON, Oct. 01, 2026 (GLOBE NEWSWIRE) — Occidental (NYSE: OXY) will announce its third quarter 2026 financial results after close of market on Monday, November 9, 2026, and will hold a conference call to discuss the results on Tuesday, November 10, 2026, at 1 p.m. Eastern/12 p.m. Central.

The conference call may be accessed by calling 1-866-871-6512 (international callers dial 1-412-317-5417) or via webcast at oxy.com/investors. Participants may pre-register for the conference call at https://dpregister.com/sreg/10212000/104e317d980.

Third quarter 2026 financial results will be available through the Investor Relations section of the company’s website. A recording of the webcast will be posted on the website within several hours after the call is completed.

About Occidental

Occidental is an international energy company that produces, markets and transports oil and natural gas to maximize value and provide resources fundamental to life. The company leverages its global leadership in carbon management to advance lower-carbon technologies and products. Headquartered in Houston, Occidental primarily operates in the United States, the Middle East and North Africa. To learn more, visit oxy.com.

Contacts

Media   Investors
Eric Moses
713-497-2017
eric_moses@oxy.com
  Babatunde A. Cole
713-552-8811
investors@oxy.com

TAMPA, Fla., Oct. 01, 2026 (GLOBE NEWSWIRE) — Slide Insurance Holdings, Inc. (“Slide”) (Nasdaq: SLDE) announced today it will release its 2026 third quarter financial results on Tuesday, October 27, 2026, after the market closes. The Company will host a conference call and live webcast on Wednesday, October 28, 2026, at 8:30 AM Eastern time.

Webcast and Conference Call Details

  • When: October 28, 2026, at 8:30 AM Eastern Time.
  • Dial-in: (877) 407-9208 (toll-free) or (201) 493-6784 (international). Please dial in 10 minutes prior to the scheduled start time.
  • Webcast: A live webcast of the conference call will be available at ir.slideinsurance.com. Following the call, a replay will be available on the Investor Relations section of Slide’s website.

About Slide

Slide Insurance Holdings, Inc. (NASDAQ: SLDE) is a Tampa-based specialty property insurer built for coastal and catastrophe-prone markets. Slide combines advanced technology with deep insurance expertise to maintain a disciplined approach to risk, bring additional capacity to the markets it serves along with its network of more than 5,000 independent agents, and provide a dependable, streamlined insurance experience to its policyholders. Slide ranks among the 25 largest U.S. homeowners insurance groups by direct written premium, according to the National Association of Insurance Commissioners (NAIC). For more information, visit slideinsurance.com.

Contacts

Investors
ir@slideinsurance.com

BRISBANE, Australia, Oct. 01, 2026 (GLOBE NEWSWIRE) — North American lithium producer Elevra Lithium Limited (“Elevra”) (ASX:ELV; NASDAQ:ELVR) provides an update on the proposed sale of its interests in the Ewoyaa Lithium Project (“Ewoyaa Project”) in Ghana to Zhejiang Huayou Cobalt Co., Ltd. (“Huayou”) where the Ghanaian Government approval process continues and Huayou has received FIRB approval for the proposed acquisition of Atlantic Lithium Limited (“Atlantic Lithium”).

As announced on 11 May 20261, Elevra entered into an agreement with Huayou for the sale of all of Elevra’s rights and interests in the Ewoyaa Project, including its associated offtake rights, for cash consideration of approximately US$71 million before fees and taxes.

Completion of the transaction remains subject to receipt of the required Ghanaian Government approvals. Huayou continues to progress the approvals process with the relevant Ghanaian authorities, with Elevra working constructively with Huayou to facilitate completion.

Under the current terms of the agreement with Huayou, if the relevant Ghanaian Government approvals have not been obtained by 30 October 2026, Huayou will have an election to either complete the transaction (and pay the cash consideration of approximately US$71 million) or terminate the transaction and pay Elevra a US$5 million break fee. In circumstances where the Ghanaian Government rejects Huayou’s application on or before 30 October 2026, then no break fee shall be payable to Elevra.

Separately, Huayou continues to progress its proposed acquisition of Atlantic Lithium2 which holds the remaining private-sector interest in the Ewoyaa Project. Atlantic Lithium has announced that Huayou has received approval from Australia’s Foreign Investment Review Board (“FIRB”) for the proposed acquisition by way of Scheme of Arrangement3 (“Scheme”).

The receipt of FIRB approval represents further progress in Huayou’s proposed acquisition of Atlantic Lithium. The Scheme remains subject to the satisfaction or waiver of its remaining conditions, including applicable shareholder, court and regulatory approvals.

As previously announced, Huayou’s proposed acquisition of Elevra’s interests in the Ewoyaa Project is separate from, and is not conditional upon, completion of Huayou’s proposed acquisition of Atlantic Lithium.

Elevra will provide a further update when there is a material development in relation to the Ghanaian Government approval process or completion of the transaction.

Elevra’s Managing Director and Chief Executive Officer, Mr. Lucas Dow, said: “Huayou continues to progress the Ghanaian Government approval process required to complete the acquisition of Elevra’s interests in the Ewoyaa Project.

“The receipt of FIRB approval for Huayou’s separate proposed acquisition of Atlantic Lithium represents further progress in Huayou’s broader proposed investment in the Ewoyaa Project. We continue to work constructively with Huayou towards completion of Elevra’s transaction.”

Announcement authorised for release by Elevra’s Managing Director and Chief Executive Officer.

About Elevra Lithium

Elevra Lithium Limited is a North American lithium producer (ASX:ELV; NASDAQ:ELVR) with projects in Québec, Canada, United States, and a joint venture in Western Australia.

Elevra’s assets comprise North American Lithium (100%), a 60% stake in the Moblan Lithium Project in Central Québec and the Carolina Lithium Project (100%) in the United States.

For more information, please visit us at www.elevra.com

For more information, please contact:

Andrew Barber
Investor Relations
PH: +617 3369 7058

___________________________________
1 See ASX announcement dated 11 May 2026, “Elevra enters agreement to sell Ewoyaa Project Interest”.
2 Atlantic Lithium Limited ASX announcement dated 7 May 2026, “Binding Scheme Implementation Deed with Huayou”.
3 Atlantic Lithium Limited ASX announcement dated 17 September 2026, “Scheme Update – FIRB Approval received for acquisition of A11”.

VERO BEACH, Florida, Oct. 01, 2026 (GLOBE NEWSWIRE) — ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) (“ARMOUR” or the “Company”) today confirmed the October 2026 cash dividend for the Company’s Common Stock, consistent with the previous guidance which the Company released on September 24, 2026. The Company also confirmed the Q4 2026 monthly cash dividend rate for the Company’s Series C Preferred Stock.

October 2026 Common Stock Dividend Information

Month   Dividend   Holder of Record Date   Payment Date
October 2026   $0.24   October 15, 2026   October 29, 2026
             

Q4 2026 Series C Preferred Stock Dividend Information

Month   Dividend   Holder of Record Date   Payment Date
October 2026   $0.14583   October 15, 2026   October 27, 2026
November 2026   $0.14583   November 15, 2026   November 27, 2026
December 2026   $0.14583   December 15, 2026   December 28, 2026
             

Certain Tax Matters

ARMOUR has elected to be taxed as a real estate investment trust (“REIT”) for U.S. Federal income tax purposes. In order to maintain this tax status, ARMOUR is required to timely distribute substantially all of its ordinary REIT taxable income. Dividends paid in excess of current tax earnings and profits for the year will generally not be taxable to common stockholders. Actual dividends are determined at the discretion of the Company’s Board of Directors, who may consider additional factors including the Company’s results of operations, cash flows, financial condition and capital requirements as well as current market conditions, expected opportunities and other relevant factors.

About ARMOUR Residential REIT, Inc.

ARMOUR invests primarily in fixed rate residential, adjustable rate and hybrid adjustable rate residential mortgage-backed securities issued or guaranteed by U.S. government-sponsored enterprises or guaranteed by the Government National Mortgage Association. ARMOUR is externally managed and advised by ARMOUR Capital Management LP, an investment advisor registered with the Securities and Exchange Commission (“SEC”).

Safe Harbor

This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. The Company disclaims any obligation to release publicly any updates or revisions to any forward-looking statement to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.

Additional Information and Where to Find It

Investors, security holders and other interested persons may find additional information regarding the Company at the SEC’s internet site at www.sec.gov, or the Company website at www.armourreit.com, or by directing requests to: ARMOUR Residential REIT, Inc., 3001 Ocean Drive, Suite 201, Vero Beach, Florida 32963, Attention: Investor Relations.

Investor Contact:

Gordon M. Harper
Chief Financial Officer
ARMOUR Residential REIT, Inc.
(772) 617-4340

PARIS and CAMBRIDGE, Mass., Oct. 01, 2026 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the “Company”), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer and other major diseases, today announced the appointment of Arnd Christ as chief financial officer and member of the Company’s executive board, effective October 1, 2026. Mr. Christ brings more than two decades of financial leadership in publicly listed biotechnology companies in Europe and the United States. He succeeds Bart Van Rhijn, who will step down as chief financial & business officer and member of the executive board after five years of service to the Company.

“Nanobiotix is at a defining point in its history, moving from a story carried primarily by one asset to one that is informed by multiple platforms,” said Mr. Christ. “I look forward to joining the team and contributing my expertise to advance these promising platforms for the benefit of patients with cancer and other major diseases.”

Mr. Christ has spent more than 25 years as chief financial officer of public and private biotechnology companies in Europe and the United States. He most recently served as chief financial officer of Immatics N.V., a Nasdaq-listed biotechnology company, from October 2020 until September 2025. Before Immatics he was chief financial officer of various private and public European biotech companies including InflaRx N.V., MediGene AG, NovImmune SA and Probiodrug AG, and served on the supervisory board of Immunocore. During his career, Arnd conducted a significant range of corporate transactions such as IPO, licensing deals and fundraising for private and publicly listed biotech companies.

“Arnd has overseen the financial needs of public companies in our industry on both sides of the Atlantic,” said Laurent Levy, co-founder and chairman of the executive board at Nanobiotix. “His experience comes at an important time for Nanobiotix as we enter our next phase of growth, and I am confident he will make a meaningful contribution to our continued progress. I also want to extend gratitude to Bart Van Rhijn for his leadership over the past 5 years, which helped drive the strengthening of both our financial and business foundation while positioning Nanobiotix for the opportunities ahead. On behalf of everyone at Nanobiotix, I thank Bart for his commitment to the company and wish him every success in his next chapter.”                                

About NANOBIOTIX

Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people committed to making a difference for humanity. The Company’s philosophy is rooted in the concept of pushing past the boundaries of what is known to expand possibilities for human life.

Incorporated in 2003, Nanobiotix is headquartered in Paris, France and is listed on Euronext Paris since 2012 and on the Nasdaq Global Select Market in New York City since December 2020. The Company has subsidiaries in Cambridge, Massachusetts (United States) amongst other locations.

Nanobiotix is the owner of more than 30 umbrella patents associated with three (3) nanotechnology platforms with applications in 1) oncology; 2) bioavailability and biodistribution; and 3) disorders of the central nervous system.

For more information about Nanobiotix, visit us at www.nanobiotix.com or follow us on LinkedIn and Twitter

Disclaimer

This press release contains “forward-looking” statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding the use of proceed therefrom, and the period of time through which the Company’s anticipates its financial resources will be adequate to support operations. Words such as “expects”, “intends”, “can”, “could”, “may”, “might”, “plan”, “potential”, “should” and “will” or the negative of these and similar expressions are intended to identify forward-looking statements. These forward-looking statements which are based on the Company’ management’s current expectations and assumptions and on information currently available to management. These forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those implied by the forward-looking statements, including risks related to Nanobiotix’s business and financial performance, which include the risk that assumptions underlying the Company’s cash runway projections are not realized. Further information on the risk factors that may affect company business and financial performance is included in Nanobiotix’s Annual Report on Form 20-F filed with the SEC on March 31, 2026 under “Item 3.D. Risk Factors”, in Nanobiotix’s 2025 universal registration document filed with the AMF on March 31, 2026 under “chapter 1.5 Risk Factors”, and subsequent filings Nanobiotix makes with the SEC and AMF from time to time, including the Half-Year Report at June 30, 2026, which are available on the SEC’s website at www.sec.gov and on the AMF’s website at www.amf.org, The forward-looking statements included in this press release speak only as of the date of this press release, and except as required by law, Nanobiotix assumes no obligation to update these forward-looking statements publicly.

Nanobiotix
Communications Department
Brandon Owens
VP, Communications
+1 (617) 852-4835
contact@nanobiotix.com
Investor Relations Department
Joanne Choi
VP, Investor Relations (US)
+1 (713) 609-3150
joanne.choi@nanobiotix.com 

Ricky Bhajun
Director, Investor Relations (EU)
+33 (0) 79 97 29 99
investors@nanobiotix.com

Media Relations
France – HARDY
Caroline Hardy
+33 06 70 33 49 50
carolinehardy@outlook.fr
Global – uncapped
Becky Lauer
+1 (646) 286-0057
uncappednanobiotix@uncappedcommunications.com

Attachment

Secures approximately 35% of quota share reinsurance coverage from a panel of third-party reinsurance providers

RALEIGH, N.C., Oct. 01, 2026 (GLOBE NEWSWIRE) — Enact Holdings, Inc. (Nasdaq: ACT) (Enact), a leading provider of private mortgage insurance through its insurance subsidiaries, today announced that its flagship legal entity, Enact Mortgage Insurance Corporation, has entered into a quota share reinsurance agreement with a panel of reinsurers each currently rated “A-” or better by Standard & Poor’s (“S&P”) or A.M. Best Company, Inc., or rated “A3” or better by Moody’s.

Under the agreement, and subject to certain conditions, Enact will cede approximately 35% of a portion of expected new insurance written for the period from January 1, 2028 through December 31, 2028.

“This agreement represents another step in the continued advancement of our CRT program and our prudent approach to managing and distributing risk,” said Rohit Gupta, President and CEO of Enact. “We remain committed to further strengthening the resilience of our portfolio while driving sustainable long-term value creation for shareholders.”

Safe Harbor Statement
This communication contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may address, among other things, our expected financial and operational results, the related assumptions underlying our expected results, guidance concerning the future return of capital and the quotations of management. These forward-looking statements are distinguished by use of words such as “will,” “may,” “would,” “anticipate,” “expect,” “believe,” “designed,” “plan,” “predict,” “project,” “target,” “could,” “should,” or “intend,” the negative of these terms, and similar references to future periods. These views involve risks and uncertainties that are difficult to predict and, accordingly, our actual results may differ materially from the results discussed in our forward-looking statements. Our forward-looking statements contained herein speak only as of the date of this press release. Factors or events that we cannot predict, including risks related to an economic downturn or a recession in the United States and in other countries around the world; changes in political, business, regulatory, and economic conditions; changes in or to Fannie Mae and Freddie Mac (the “GSEs”), whether through Federal legislation, restructurings or a shift in business practices; failure to continue to meet the mortgage insurer eligibility requirements of the GSEs; competition for customers; lenders or investors seeking alternatives to private mortgage insurance; an increase in the number of loans insured through Federal government mortgage insurance programs, including those offered by the Federal Housing Administration; and other factors described in the risk factors contained in our most recent Annual Report on Form 10-K and other filings with the SEC, may cause our actual results to differ from those expressed in forward-looking statements. Although Enact believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, Enact can give no assurance that its expectations will be achieved and it undertakes no obligation to update publicly any forward-looking statements as a result of new information, future events, or otherwise, except as required by applicable law.

About Enact Holdings, Inc.
Enact (Nasdaq: ACT), operating principally through its wholly-owned subsidiary Enact Mortgage Insurance Corporation since 1980, is a leading U.S. private mortgage insurance provider committed to helping more people achieve the dream of homeownership. Building on a deep understanding of lenders’ businesses and a legacy of financial strength, we partner with lenders to bring best-in class service, leading underwriting expertise, and extensive risk and capital management to the mortgage process, helping to put more people in homes and keep them there. By empowering customers and their borrowers, Enact seeks to positively impact the lives of those in the communities in which it serves in a sustainable way. Enact is headquartered in Raleigh, North Carolina.

This press release was published by a CLEAR® Verified individual.

CONTACT: Investor Contact
Jonathan Fleetwood
EnactIR@enactmi.com

Media Contact
Sarah Wentz
Sarah.Wentz@enactmi.com

PALM BEACH, Fla., Oct. 01, 2026 (GLOBE NEWSWIRE) — GAMCO Investors, Inc. (“Gabelli”) (OTCQX: GAMI) announced today that assets under management (“AUM”) were $35.2 billion at September 30, 2026 as compared to $35.0 billion at September 30, 2025.

Gabelli expects to report third quarter 2026 diluted earnings in the range of $0.60 to $0.66 per share versus $0.68 per share for the third quarter of 2025.

Gabelli plans to review further details of its financial results in early November.

About GAMCO Investors, Inc.

Gabelli (OTCQX: GAMI), established in 1977, is a widely-recognized provider of investment advisory services to 27 open-end funds, 13 United States closed-end funds and one United Kingdom limited investment company, 8 actively managed exchange traded funds, one société d’investissement à capital variable, and approximately 1,700 institutional and private wealth management investors principally in the U.S. The Company’s revenues are based primarily on the levels of assets under management and fees associated with the various investment products.

In 1977, Gabelli launched its well-known All Cap Value equity strategy, Gabelli Value, in a separate account format and in 1986 entered the mutual fund business. Today, Gabelli offers a diverse set of client solutions across asset classes (e.g. Equities, Debt Instruments, Convertibles, non-market correlated Merger Arbitrage), regions, market capitalizations, sectors (e.g. Gold, Utilities) and investment styles (e.g. Value, Growth). Gabelli serves a broad client base, including institutions, intermediaries, offshore investors, private wealth, and direct retail investors.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

The financial results set forth in this press release are preliminary. Our disclosure and analysis in this press release, which do not present historical information, contain “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995.  Forward-looking statements convey our current expectations or forecasts of future events. You can identify these statements because they do not relate strictly to historical or current facts. They use words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” and other words and terms of similar meaning. They also appear in any discussion of future operating or financial performance. In particular, these include statements relating to future actions, future performance of our products, expenses, the outcome of any legal proceedings, and financial results. Although we believe that we are basing our expectations and beliefs on reasonable assumptions within the bounds of what we currently know about our business and operations, the economy, and other conditions, there can be no assurance that our actual results will not differ materially from what we expect or believe. Therefore, you should proceed with caution in relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance.

Forward-looking statements involve a number of known and unknown risks, uncertainties and other important factors, some of which are listed below, that are difficult to predict and could cause actual results and outcomes to differ materially from any future results or outcomes expressed or implied by such forward-looking statements. Some of the factors that may cause our actual results to differ from our expectations include risks associated with a decline in the securities markets that adversely affect our assets under management, negative performance of our products, the failure to perform as required under our investment management agreements, and a general downturn in the economy that negatively impacts our operations. We also direct your attention to the more specific discussions of these and other risks, uncertainties and other important factors contained in our Annual Report and other public filings. Other factors that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We do not undertake to update publicly any forward-looking statements if we subsequently learn that we are unlikely to achieve our expectations whether as a result of new information, future developments or otherwise, except as may be required by law.

Contact:    
Kieran Caterina
SVP, Chief Accounting Officer
(914) 921-5149

For further information please visit
www.gabelli.com

Divestiture of non-strategic assets supports a stronger balance sheet and investment in new-to-industry stores in faster-growing core markets

FORT WORTH, Texas, Oct. 01, 2026 (GLOBE NEWSWIRE) — Yesway, Inc. (“Yesway” or the “Company”) (Nasdaq: YSWY), one of the fastest-growing convenience store operators in the United States, today announced that it has completed the sale of its 29-store portfolio in Iowa and Kansas to Now & Forever for approximately $21 million, including payment for the value of existing inventory.

The transaction advances Yesway’s disciplined capital allocation strategy of monetizing non-strategic assets and redeploying capital into investments with higher return potential in faster-growing markets. The Company intends to use the proceeds to further strengthen its balance sheet and support the development of new-to-industry stores in its core markets, where it believes its established brands and proven operating capabilities position it to generate attractive returns and sustainable long-term growth.

“This transaction is fundamentally about putting our capital to work where we believe it can generate the greatest long-term value,” said Thomas N. Trkla, Chairman, President and Chief Executive Officer of Yesway. “By monetizing our Iowa and Kansas portfolio, we are unlocking capital to invest in new-to-industry stores in faster-growing core markets where we see opportunities to achieve higher returns on invested capital. At the same time, we are sharpening our operational focus and simplifying our supply chain footprint. Together, these benefits position us to pursue more profitable growth, build on the strength of our Yesway and Allsup’s brands and deliver long-term value for our shareholders.”

“I also want to express my heartfelt thanks to all of our district and store managers, service technicians, and store associates in Iowa and Kansas for their hard work, dedication, and commitment throughout the years these stores have been part of the Yesway family,” Mr. Trkla added. “Their pride in their work, care for our customers, and dedication to their communities helped build the foundation of our company, and I am tremendously proud of all that we accomplished together.”

About Yesway

Established in 2015 and headquartered in Fort Worth, TX, Yesway is an award-winning convenience store operator with approximately 420 stores across eight states in the Midwest and Southwest. Yesway is renowned for its iconic foodservice offerings, diverse grocery selections, and private-label products, including the famous Allsup’s deep-fried burrito. Through strategic acquisitions, the development and opening of more than 90 stores over the past several years, and a steadfast commitment to customer satisfaction and community engagement, Yesway continues to cement its position as one of the leading convenience retailers in the United States.    

Investor Contact:
IR@yesway.com

Media Contact:
Erin Vadala
evadala@boltpr.com

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.